SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Elder Pharmaceuticals reports 10% fall in Q1 net profit

10 Aug 2012 Evaluate

Elder Pharmaceuticals has reported results for first quarter ended June 30, 2012.

The company has reported fall of 9.94% in its net profit at Rs 18.04 crore for the quarter under review as compared to Rs 20.03 crore for the same quarter in the previous year. However, the total income from operation of the company has increased by 18% at Rs 353.98 crore for Q1FY13 as compared Rs 299.99 crore for the corresponding quarter previous year.

Elder Pharmaceuticals (EPL) has around six manufacturing units in India, all as per international standards. Post increasing its stake in Elder Biomeda AD and Neutrahealth PLC, EPL also has access to the manufacturing units of these companies in Bulgaria and Birmingham, UK respectively coupled with distribution network and brands of the same.

Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×